First Treatment to Delay Type 1 Diabetes Licensed in the US

A Doctor Checking a Child

On 17/11/22 teplizumab was approved by the US Food and Drug Administration (FDA) as the first ever treatment indicated to delay the onset of stage 3 type 1 diabetes. This is the biggest treatment breakthrough for the condition since the discovery of insulin 100 years ago.

Although teplizumab is not approved in the UK yet, the US approval paves the way for this life-changing treatment to be made available to people at high risk of developing type 1 diabetes in the UK too.

Listen to this Podcast

Find out more